---
figid: PMC9333350__41416_2022_1876_Sch1_HTML
figtitle: TLR9 signaling pathways
organisms:
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC9333350
filename: 41416_2022_1876_Sch1_HTML.jpg
figlink: /pmc/articles/PMC9333350/figure/Sch1/
number: S1
caption: The binding of CpG-ODN to TLR9 leads to the activation of type I IFN signaling
  pathway, NF-κB signaling pathway and MAPK signaling pathway, which promotes the
  expression and release of pro-inflammatory cytokines in target cells.
papertitle: 'Toll-like receptor 9 agonists and combination therapies: strategies to
  modulate the tumour immune microenvironment for systemic anti-tumour immunity.'
reftext: Zhangchi Dongye, et al. Br J Cancer. 2022 Jul 28 ;127(9):1584-1594.
year: '2022'
doi: 10.1038/s41416-022-01876-6
journal_title: British Journal of Cancer
journal_nlm_ta: Br J Cancer
publisher_name: Nature Publishing Group UK
keywords: Drug development | Cancer immunotherapy
automl_pathway: 0.9434869
figid_alias: PMC9333350__S1
figtype: Scheme
redirect_from: /figures/PMC9333350__S1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9333350__41416_2022_1876_Sch1_HTML.html
  '@type': Dataset
  description: The binding of CpG-ODN to TLR9 leads to the activation of type I IFN
    signaling pathway, NF-κB signaling pathway and MAPK signaling pathway, which promotes
    the expression and release of pro-inflammatory cytokines in target cells.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - UNC93B1
  - MYD88
  - IRF7
  - IFNA1
  - TLR9
  - IRAK4
  - IRAK1
  - CHUK
  - IKBKB
  - IKBKG
  - IKBKE
  - TBK1
  - SCN11A
  - TRAF6
  - NFKB1
  - MAPK1
  - MAPK3
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - unc93b1
  - myd88
  - irf7
  - ifnphi1
  - tlr9
  - irak4
  - irak1
  - traf6
---
